Healthcare Realty Trust Incorporated

HRNYSECIK 1360604Real Estate / REITsfiscal year ends December66 quarters since 2010

Revenue, Q3 FY2026
$287M
−3.7% on Q3 FY2025
Net income
−$16M
+72.7% on Q3 FY2025
Free cash flow
—
no year-earlier figure
Diluted EPS
$-0.05
+70.6% on Q3 FY2025
Revenue, TTM
$1.1B
trailing four quarters
Net margin, TTM
-4.0%
net income −$45M
Free cash flow, TTM
—
Cash and equivalents
$17M
long-term debt $4.2B, Sep 30, 2026
Shares, 12-month change
−3.7%
339M shares, Sep 30, 2026
Buybacks, TTM
$3M
0.1% of market value
Dividends, TTM
$333M
5.1% of market value
Market value
$6.5B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 29, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Healthcare Realty Trust Incorporated reported revenue of $287M, −3.7% on Q3 FY2025, and net loss of $16M (+72.7%). Diluted earnings per share were $-0.05.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

HR daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $19.22 · H $19.37 · L $19.08 · C $19.32 · +0.84% on the dayOver the range: +6.86%, Nov 14, 2025 to Nov 13, 2026
$16$18$19$21$22Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 29, 2026.

Revenue and net incomeRevenueNet income
−$400M−$200M$0$200M$400MQ4'22, Revenue: $338MQ4'22, Net income: −$36MQ4'22Q1'23, Revenue: $333MQ1'23, Net income: −$87MQ1'23Q2'23, Revenue: $338MQ2'23, Net income: −$83MQ2'23Q3'23, Revenue: $342MQ3'23, Net income: −$68MQ3'23Q4'23, Revenue: $330MQ4'23, Net income: −$41MQ4'23Q1'24, Revenue: $327MQ1'24, Net income: −$311MQ1'24Q2'24, Revenue: $316MQ2'24, Net income: −$144MQ2'24Q3'24, Revenue: $315MQ3'24, Net income: −$93MQ3'24Q4'24, Revenue: $310MQ4'24, Net income: −$107MQ4'24Q1'25, Revenue: $299MQ1'25, Net income: −$45MQ1'25Q2'25, Revenue: $298MQ2'25, Net income: −$158MQ2'25Q3'25, Revenue: $298MQ3'25, Net income: −$58MQ3'25Q4'25, Revenue: $286MQ4'25, Net income: $14MQ4'25Q1'26, Revenue: $279MQ1'26, Net income: −$56KQ1'26Q2'26, Revenue: $282MQ2'26, Net income: −$44MQ2'26Q3'26, Revenue: $287MQ3'26, Net income: −$16MQ3'26−$400M−$200M$0$200M$400MQ4'22, Revenue: $338MQ4'22, Net income: −$36MQ4'22Q1'23, Revenue: $333MQ1'23, Net income: −$87MQ1'23Q2'23, Revenue: $338MQ2'23, Net income: −$83MQ2'23Q3'23, Revenue: $342MQ3'23, Net income: −$68MQ3'23Q4'23, Revenue: $330MQ4'23, Net income: −$41MQ4'23Q1'24, Revenue: $327MQ1'24, Net income: −$311MQ1'24Q2'24, Revenue: $316MQ2'24, Net income: −$144MQ2'24Q3'24, Revenue: $315MQ3'24, Net income: −$93MQ3'24Q4'24, Revenue: $310MQ4'24, Net income: −$107MQ4'24Q1'25, Revenue: $299MQ1'25, Net income: −$45MQ1'25Q2'25, Revenue: $298MQ2'25, Net income: −$158MQ2'25Q3'25, Revenue: $298MQ3'25, Net income: −$58MQ3'25Q4'25, Revenue: $286MQ4'25, Net income: $14MQ4'25Q1'26, Revenue: $279MQ1'26, Net income: −$56KQ1'26Q2'26, Revenue: $282MQ2'26, Net income: −$44MQ2'26Q3'26, Revenue: $287MQ3'26, Net income: −$16MQ3'26−$400M−$200M$0$200M$400MQ4'22, Revenue: $338MQ4'22, Net income: −$36MQ1'23, Revenue: $333MQ1'23, Net income: −$87MQ1'23Q2'23, Revenue: $338MQ2'23, Net income: −$83MQ3'23, Revenue: $342MQ3'23, Net income: −$68MQ3'23Q4'23, Revenue: $330MQ4'23, Net income: −$41MQ1'24, Revenue: $327MQ1'24, Net income: −$311MQ1'24Q2'24, Revenue: $316MQ2'24, Net income: −$144MQ3'24, Revenue: $315MQ3'24, Net income: −$93MQ3'24Q4'24, Revenue: $310MQ4'24, Net income: −$107MQ1'25, Revenue: $299MQ1'25, Net income: −$45MQ1'25Q2'25, Revenue: $298MQ2'25, Net income: −$158MQ3'25, Revenue: $298MQ3'25, Net income: −$58MQ3'25Q4'25, Revenue: $286MQ4'25, Net income: $14MQ1'26, Revenue: $279MQ1'26, Net income: −$56KQ1'26Q2'26, Revenue: $282MQ2'26, Net income: −$44MQ3'26, Revenue: $287MQ3'26, Net income: −$16MQ3'26

Net income losses drawn in red.

Free cash flow
$0$50M$100M$150MQ4'22Q1'23Q2'23Q3'23, Free cash flow: $118MQ3'23Q4'23Q1'24Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26$0$50M$100M$150MQ4'22Q1'23Q2'23Q3'23, Free cash flow: $118MQ3'23Q4'23Q1'24Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26$0$50M$100M$150MQ1'23Q3'23, Free cash flow: $118MQ3'23Q1'24Q3'24Q1'25Q3'25Q1'26Q3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$2B$4B$6BQ4'22, Cash and equivalents: $61MQ4'22, Long-term debt: $5.4BQ4'22Q1'23, Cash and equivalents: $50MQ1'23, Long-term debt: $5.4BQ1'23Q2'23, Cash and equivalents: $36MQ2'23, Long-term debt: $5.3BQ2'23Q3'23, Cash and equivalents: $25MQ3'23, Long-term debt: $5.2BQ3'23Q4'23, Cash and equivalents: $26MQ4'23, Long-term debt: $5.0BQ4'23Q1'24, Cash and equivalents: $26MQ1'24, Long-term debt: $5.1BQ1'24Q2'24, Cash and equivalents: $42MQ2'24, Long-term debt: $5.1BQ2'24Q3'24, Cash and equivalents: $23MQ3'24, Long-term debt: $5.0BQ3'24Q4'24, Cash and equivalents: $69MQ4'24, Long-term debt: $4.7BQ4'24Q1'25, Cash and equivalents: $26MQ1'25, Long-term debt: $4.7BQ1'25Q2'25, Cash and equivalents: $26MQ2'25, Long-term debt: $4.7BQ2'25Q3'25, Cash and equivalents: $43MQ3'25, Long-term debt: $4.5BQ3'25Q4'25, Cash and equivalents: $26MQ4'25, Long-term debt: $3.9BQ4'25Q1'26, Cash and equivalents: $26MQ1'26, Long-term debt: $4.1BQ1'26Q2'26, Cash and equivalents: $19MQ2'26, Long-term debt: $4.2BQ2'26Q3'26, Cash and equivalents: $17MQ3'26, Long-term debt: $4.2BQ3'26$0$2B$4B$6BQ4'22, Cash and equivalents: $61MQ4'22, Long-term debt: $5.4BQ4'22Q1'23, Cash and equivalents: $50MQ1'23, Long-term debt: $5.4BQ1'23Q2'23, Cash and equivalents: $36MQ2'23, Long-term debt: $5.3BQ2'23Q3'23, Cash and equivalents: $25MQ3'23, Long-term debt: $5.2BQ3'23Q4'23, Cash and equivalents: $26MQ4'23, Long-term debt: $5.0BQ4'23Q1'24, Cash and equivalents: $26MQ1'24, Long-term debt: $5.1BQ1'24Q2'24, Cash and equivalents: $42MQ2'24, Long-term debt: $5.1BQ2'24Q3'24, Cash and equivalents: $23MQ3'24, Long-term debt: $5.0BQ3'24Q4'24, Cash and equivalents: $69MQ4'24, Long-term debt: $4.7BQ4'24Q1'25, Cash and equivalents: $26MQ1'25, Long-term debt: $4.7BQ1'25Q2'25, Cash and equivalents: $26MQ2'25, Long-term debt: $4.7BQ2'25Q3'25, Cash and equivalents: $43MQ3'25, Long-term debt: $4.5BQ3'25Q4'25, Cash and equivalents: $26MQ4'25, Long-term debt: $3.9BQ4'25Q1'26, Cash and equivalents: $26MQ1'26, Long-term debt: $4.1BQ1'26Q2'26, Cash and equivalents: $19MQ2'26, Long-term debt: $4.2BQ2'26Q3'26, Cash and equivalents: $17MQ3'26, Long-term debt: $4.2BQ3'26$0$2B$4B$6BQ4'22, Cash and equivalents: $61MQ4'22, Long-term debt: $5.4BQ1'23, Cash and equivalents: $50MQ1'23, Long-term debt: $5.4BQ1'23Q2'23, Cash and equivalents: $36MQ2'23, Long-term debt: $5.3BQ3'23, Cash and equivalents: $25MQ3'23, Long-term debt: $5.2BQ3'23Q4'23, Cash and equivalents: $26MQ4'23, Long-term debt: $5.0BQ1'24, Cash and equivalents: $26MQ1'24, Long-term debt: $5.1BQ1'24Q2'24, Cash and equivalents: $42MQ2'24, Long-term debt: $5.1BQ3'24, Cash and equivalents: $23MQ3'24, Long-term debt: $5.0BQ3'24Q4'24, Cash and equivalents: $69MQ4'24, Long-term debt: $4.7BQ1'25, Cash and equivalents: $26MQ1'25, Long-term debt: $4.7BQ1'25Q2'25, Cash and equivalents: $26MQ2'25, Long-term debt: $4.7BQ3'25, Cash and equivalents: $43MQ3'25, Long-term debt: $4.5BQ3'25Q4'25, Cash and equivalents: $26MQ4'25, Long-term debt: $3.9BQ1'26, Cash and equivalents: $26MQ1'26, Long-term debt: $4.1BQ1'26Q2'26, Cash and equivalents: $19MQ2'26, Long-term debt: $4.2BQ3'26, Cash and equivalents: $17MQ3'26, Long-term debt: $4.2BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

Healthcare Realty Trust Incorporated income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Jul 30, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 13, 2026Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 19, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue287282279286298298299310−3.7%
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative1214171422231434−42.9%
Operating income—————————
Other income (expense)(58)(83)(32)(19)(83)(176)(64)(107)+30.4%
Pretax income—————————
Income tax—————————
Net income(16)(44)014(58)(158)(45)(107)+72.7%
Diluted EPS ($)(0.05)(0.13)0.00—(0.17)(0.45)(0.13)—+70.6%
Diluted shares (millions)341342347—350350350——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

Healthcare Realty Trust Incorporated balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Jul 30, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 13, 2026Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 19, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents1719262643262669−59.6%
Short-term investments—————————
Total current assets—————————
Total assets8,9609,0019,1489,2119,86010,23610,49610,651−9.1%
Total current liabilities—————————
Long-term debt4,2494,1674,1043,9114,4864,6944,7334,663−5.3%
Total debt4,2494,1674,1043,9114,4864,6944,7334,663−5.3%
Total liabilities4,8254,7284,6514,5345,1155,3545,3495,345−5.7%
Stockholders’ equity4,0804,2174,4394,6174,6834,8175,0785,235−12.9%
Shares outstanding (millions)339343347349352352351351—

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

Healthcare Realty Trust Incorporated cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Jul 30, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 13, 2026Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 19, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow1221425313211416348138+7.5%
Capital expenditures—————————
Free cash flow (CFO − capex)—————————
Depreciation and amortization128128129withheldwithheldwithheldwithheld160—
Share repurchases01203009−98.5%
Dividends paid8282848485109109110−3.0%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 13, 2026.

Income statement

Healthcare Realty Trust Incorporated income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 13, 2026FY2024ended Dec 31, 2024filed Feb 19, 2025FY2023ended Dec 31, 2023filed Feb 16, 2024FY2022ended Dec 31, 2022filed Mar 1, 2023FY2021ended Dec 31, 2021filed Mar 1, 2022FY2020ended Dec 31, 2020filed Feb 24, 2021FY2019ended Dec 31, 2019filed Feb 18, 2020FY2018ended Dec 31, 2018filed Feb 19, 2019FY2017ended Dec 31, 2017filed Feb 20, 2018FY2016ended Dec 31, 2016filed Feb 21, 2017FY2015ended Dec 31, 2015filed Feb 22, 2016FY2014ended Dec 31, 2014filed Feb 23, 2015FY2013ended Dec 31, 2013filed Feb 25, 2014FY2012ended Dec 31, 2012filed Mar 1, 2013FY2011ended Dec 31, 2011filed Mar 27, 2012FY2010ended Dec 31, 2010filed Aug 15, 2011FY2009ended Dec 31, 2009filed Aug 15, 2011
Revenue1,1811,2681,344933535500692696614461404372322300272203129
Cost of revenue—————————————————
Gross profit—————————————————
Research and development—————————————————
Selling, general and administrative7383585334314135332926252422211612
Operating income————————124102948366304622(1)
Other income (expense)(342)(697)(336)65(15)(7)1000(1)0000——
Pretax income—————————————————
Income tax—————————————————
Net income(246)(654)(278)416772302136446334524(24)6(8)(25)
Diluted EPS ($)(0.71)(1.81)(0.74)0.150.450.520.141.020.340.330.260.370.21(0.22)0.02(0.05)(0.22)
Diluted shares (millions)350366379254143134210210185140128121115111224166113

Balance sheet

Healthcare Realty Trust Incorporated balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 13, 2026FY2024ended Dec 31, 2024filed Feb 19, 2025FY2023ended Dec 31, 2023filed Feb 16, 2024FY2022ended Dec 31, 2022filed Mar 1, 2023FY2021ended Dec 31, 2021filed Mar 1, 2022FY2020ended Dec 31, 2020filed Feb 24, 2021FY2019ended Dec 31, 2019filed Feb 18, 2020FY2018ended Dec 31, 2018filed Feb 19, 2019FY2017ended Dec 31, 2017filed Feb 20, 2018FY2016ended Dec 31, 2016filed Feb 21, 2017FY2015ended Dec 31, 2015filed Feb 22, 2016FY2014ended Dec 31, 2014filed Feb 23, 2015FY2013ended Dec 31, 2013filed Feb 25, 2014FY2012ended Dec 31, 2012filed Mar 1, 2013FY2011ended Dec 31, 2011filed Mar 27, 2012FY2010ended Dec 31, 2010filed Aug 15, 2011FY2009ended Dec 31, 2009filed Aug 15, 2011
Cash and equivalents26692661131153312610011131018166929219
Short-term investments—————————————————
Total current assets—————————————————
Total assets9,21110,65112,63713,8504,2596,7916,6396,1886,4503,7483,1723,0312,7522,4142,2922,272—
Total current liabilities—————————————————
Long-term debt3,9114,6634,9955,3521,8013,0272,7502,5412,7811,7691,5911,4021,2141,037639——
Total debt3,9114,6634,9955,3521,8013,0272,7502,5412,7811,7691,5911,4021,2141,037639——
Total liabilities4,5345,3455,7146,1682,0743,5563,2082,8473,0791,9631,7611,5511,3491,146721781—
Stockholders’ equity4,6175,2356,8237,5712,1851,9483,3583,2563,2791,6871,3791,4471,3871,2541,5671,4871,071
Shares outstanding (millions)349351381381229219217205205142131125237—230——

Cash flow statement

Healthcare Realty Trust Incorporated cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 13, 2026FY2024ended Dec 31, 2024filed Feb 19, 2025FY2023ended Dec 31, 2023filed Feb 16, 2024FY2022ended Dec 31, 2022filed Mar 1, 2023FY2021ended Dec 31, 2021filed Mar 1, 2022FY2020ended Dec 31, 2020filed Feb 24, 2021FY2019ended Dec 31, 2019filed Feb 18, 2020FY2018ended Dec 31, 2018filed Feb 19, 2019FY2017ended Dec 31, 2017filed Feb 20, 2018FY2016ended Dec 31, 2016filed Feb 21, 2017FY2015ended Dec 31, 2015filed Feb 22, 2016FY2014ended Dec 31, 2014filed Feb 23, 2015FY2013ended Dec 31, 2013filed Feb 25, 2014FY2012ended Dec 31, 2012filed Mar 1, 2013FY2011ended Dec 31, 2011filed Mar 27, 2012FY2010ended Dec 31, 2010filed Aug 15, 2011FY2009ended Dec 31, 2009filed Aug 15, 2011
Operating cash flow4575025002732334703403373082041911681481171125922
Capital expenditures————9775927865432929252316159
Free cash flow (CFO − capex)————13539524926024316116213912294964413
Depreciation and amortization5646757314532031902902802451771541401221161077954
Share repurchases492341127033211183385216
Dividends paid38745847228417516325625320715914613712993856040

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$401K
1 sales by 1 insider; officers and directors $401K
Bought, twelve months
$181K
2 purchases by 2 insiders; officers and directors $181K
Sold, twelve months
$926K
2 sales by 2 insiders; officers and directors $926K

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Sep 8, 2026Hull Robert EEVP and COOopen-market sale21,000$19.11$401K276,338Sep 9, 2026
Jun 23, 2026Callaway Amanda LSVP & Chief Accounting Officeropen-market sale25,767$20.37$525K109,954Jun 23, 2026
May 19, 2026Bohjalian Thomas NDirectoraward6,683$20.20$135K92,203May 20, 2026
May 19, 2026Henry DavidDirectoraward6,683$20.20$135K15,701May 20, 2026
May 19, 2026Moore Constance BDirectoraward6,683$20.20$135K91,221May 20, 2026
May 19, 2026Rufrano Glenn JDirectoraward6,683$20.20$135K25,701May 20, 2026
May 19, 2026Wood Donald CDirectoraward6,683$20.20$135K21,601May 20, 2026
Apr 14, 2026Scott Peter APresident and CEOtax withholding36,029$17.84$643K556,422Apr 15, 2026
Mar 6, 2026Bohjalian Thomas NDirectoropen-market buy10,000$18.09$181K85,520Mar 6, 2026
Mar 4, 2026Gabbay DanielEVP, Chief Financial Officeropen-market buyindirect10$18.74$18710Mar 5, 2026
Feb 13, 2026Crowley Ryan E.EVP and CIOtax withholding736$17.96$13K198,504Feb 17, 2026
Feb 10, 2026Crowley Ryan E.EVP and CIOtax withholding2,905$17.36$50K199,240Feb 11, 2026
Feb 10, 2026Loope Andrew EdwardEVP, General Counseltax withholding3,650$17.36$63K184,486Feb 11, 2026
Feb 10, 2026Callaway Amanda LSVP & Chief Accounting Officertax withholding1,623$17.36$28K135,721Feb 11, 2026
Feb 10, 2026Hull Robert EEVP and COOtax withholding4,097$17.36$71K297,338Feb 11, 2026
Feb 10, 2026Scott Peter APresident and CEOtax withholding10,820$17.36$188K592,451Feb 11, 2026
Feb 9, 2026Gabbay DanielEVP, Chief Financial Officeraward32,107$17.13$550K191,158Feb 25, 2026
Feb 9, 2026Crowley Ryan E.EVP and CIOaward32,788$17.13$562K203,113Feb 11, 2026
Feb 9, 2026Crowley Ryan E.EVP and CIOtax withholding968$17.13$17K202,145Feb 11, 2026
Feb 9, 2026Loope Andrew EdwardEVP, General Counseltax withholding2,924$17.13$50K188,136Feb 11, 2026
Feb 9, 2026Loope Andrew EdwardEVP, General Counselaward32,588$17.13$558K191,060Feb 11, 2026
Feb 9, 2026Callaway Amanda LSVP & Chief Accounting Officeraward34,689$17.13$594K140,113Feb 11, 2026
Feb 9, 2026Callaway Amanda LSVP & Chief Accounting Officertax withholding2,769$17.13$47K137,344Feb 11, 2026
Feb 9, 2026Hull Robert EEVP and COOtax withholding5,915$17.13$101K301,435Feb 11, 2026
Feb 9, 2026Hull Robert EEVP and COOaward33,859$17.13$580K307,350Feb 11, 2026

Full insider history for Healthcare Realty Trust Incorporated, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held HR in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded HR by quarter.

FundManagerQuarterValueSharesWeightMove
Renaissance TechnologiesPeter BrownQ3 2026$52M3M0.07%added +14.6%

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
HEALTHCARE REALTY TRUST INCORPORATED, CIK 1360604 on EDGAR
Extract generated
November 16, 2026
Withheld
5 line-years whose four quarters do not sum to the filed year: other income FY2011, depreciation amortization FY2012, other income FY2012, depreciation amortization FY2021, depreciation amortization FY2025
Repaired
1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: net income FY2022
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: not filed
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: not filed
Income tax: not filed
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: not filed
Total assets: Assets
Total current liabilities: not filed
Long-term debt: LongTermDebt
Total debt: LongTermDebt, combined
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/HR.json